Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3 cutaneous melanoma, according to the results of a single-arm phase 2 clinical trial led by the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute (NCI).
CVS Health Appoints David Joyner as New CEO
What You Should Know: – CVS Health has announced the appointment of David Joyner as its new President and Chief Executive Officer, effective October 17,
October 18, 2024